Optimization of estrogen receptor analysis by immunocytochemistry in random periareolar fine-needle aspiration samples of breast tissue processed as thin-layer preparations

Applied Immunohistochemistry and Molecular Morphology

Volumn 14, Issue 3, 2006, Pages 360-364

  Petroff, Brian K ^a,b   Clark, Julie L ^a   Metheny, Trina ^a   Xue, Qiao ^a   Kimler, Bruce F ^a,b   Fabian, Carol J ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Breast; Estrogen receptor; Fine needle aspiration; Immunohistochemistry; Prevention

Indexed keywords

BUFFER; CITRIC ACID; ESTROGEN RECEPTOR ALPHA; GLUCOSE OXIDASE; HYDROGEN PEROXIDE;

ANTIBODY TITER; ANTIGEN RETRIEVAL; ARTICLE; ASPIRATION BIOPSY; BREAST; BREAST EPITHELIUM; CELL STRAIN MCF 7; CONTROLLED STUDY; HIGH TEMPERATURE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PREVALENCE; PRIORITY JOURNAL;

ANTIBODIES; ANTIGENS; BIOPSY, FINE-NEEDLE; BREAST; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; HUMANS; IMMUNOHISTOCHEMISTRY; STAINING AND LABELING;

EID: 33748249021     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/00129039-200609000-00017     Document Type: Article

References (28)

1. Osborne CK, Yochmowitz MG, Knight WA, et al. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer. 1980;46:2884-2888.
2. Knight WA, Livingston RB, Gregory EJ, et al. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977;37:4669-4671.
3. Pichon MF, Broet P, Magdelenat H, et al. Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. Br J Cancer. 1996;73:1545-1551.
4. Allred DC, Mohsin SK, Fuqua SAW. Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer. 2001;8:47-61.
5. Khan SA, Yee KA, Kaplan C, et al. Estrogen receptor alpha expression in normal human breast epithelium is consistent over time. Int J Cancer. 2002;102:334-337.
6. Shaaban AM, Sloane JP, West CR, et al. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor alpha and Ki-67 expression. Am J Pathol. 2002;160:597-604.
7. Deligeorgi-Politi H, Bartziota EV, Mavrogeorgis A, et al. Determination of estrogen receptors in cytologic imprints of breast cancers using immunocytochemical methods. Acta Cytol. 1990;34:881-884.
8. Colley M, Kommoss F, Bibbo M, et al. Assessment of hormone receptors in breast carcinoma by immunocytochemistry and image analysis. II. Estrogen receptors. Anal Quant Cytol Histol. 1989;11:307-314.
9. Tajford S, Bohler PJ, Risberg B, et al. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry. Diagn Cytopathol. 2002;26:137-141.
10. Diaz LK, Sneige N. Estrogen receptor analysis for breast cancer. Current issues and keys to increasing testing accuracy. Adv Anat Pathol. 2005;12:10-19.
11. Kuenen-Boumeester V, Timmermans AM, DeBruijn EM, et al. Immunocytochemical detection of prognostic markers in breast cancer; technical considerations. Cytopathology. 1999;10:308-316.
12. Lee H, Douglas-Jones AG, Morgan JM, et al. The effect of fixation and processing on the sensitivity of estrogen receptor assay by immunohistochemistry in breast carcinoma. J Clin Pathol. 2002;55:236-238.
13. Fabian CJ, Kimler BF, Elledge RM, et al. Models for early chemoprevention trials in breast cancer. Cancer Chemoprevention. 1998;12:993-1017.
14. Fabian CJ. Benign breast tissue sampling for prevention studies. Breast J. 2000;6:215-219.
15. Fabian CJ, Kimler BF, Zalles CM, et al. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst. 2000;92:1217-1227.
16. Fabian CJ, Kimler BF. Beyond tamoxifen: new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention. Ann NY Acad Sci. 2001;952:44-59.
17. Goldstein NS, Ferkowicz M, Odish E, et al. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am J Clin Pathol. 2003;120:86-92.
18. Grizzle WE, Meyers RB, Oelschlager DK. Prognostic biomarkers in breast cancer: factors affecting immunohistochemical evaluation. Breast J. 1995;1:243-250.
19. Steele RGD, Torrie JH. Analysis of Variance II: Multiway Classification. In: Napier C, Maisel JW, eds. Principles and Procedures of Statistics: A Biometric Approach. New York: McGraw-Hill; 1980, 236-237.
20. Frost AR, Sparks D, Grizzle WE. Methods of antigen recovery vary in their usefulness in unmasking specific antigens in immunohistochemistry. Appl Immunohistochem Mol Morphol. 2000;8:236-243.
21. Rhodes A, Jasani B, Balaton AJ, et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. Am J Clin Pathol. 2001;115:44-58.
22. Pelosi G, Bresaola E, Rodella S, et al. Expression of proliferating cell nuclear antigen, Ki-67 antigen, estrogen receptor protein and tumor suppressor p53 gene in cytologic samples of breast cancer: an immunochemical study with clinical, pathobiological and histological correlations. Diagn Cytopathol. 1994;11:131-140.
23. Confortini M, Carozzi F, Bozzola L, et al. Interlaboratory reproducibility of the immunocytochemical assessment of oestrogen and progesterone receptors and proliferative activity in fine-needle aspiration of breast cancer. Cytopathology. 2002;13:92-100.
24. Shidham VB, Chang CC, Rao RN, et al. Immunostaining of cytology smears: a comparative study to identify the most suitable method of smear preparation and fixation with reference to commonly used immunomarkers. Diagn Cytopathol. 2003;29:217-221.
25. Krishnamurthy S, Dimashkieh H, Patel S, et al. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears. Diagn Cytopathol. 2003;29:309-314.
26. Leung SW, Bedard YC. Estrogen and progesterone receptor contents in ThinPrep-processed fine-needle aspirates of the breast. Am J Clin Pathol. 1999;112:50-56.
27. Gong Y, Symmans WF, Krishnamurthy S, et al. Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma. Cancer Cytopathol. 2004;102:34-40.
28. Umemura S, Itoh H, Ohta M, et al. Immunohistochemical evaluation of hormone receptor for routine practice of breast cancer: highly sensitive procedures significantly contribute to the correlation with biochemical assays. Appl Immunohistochem Mol Morphol. 2003;11:62-72.